Arcturus Therapeutics (ARCT) Revenue (2018 - 2026)
Arcturus Therapeutics (ARCT) revenue from Jun 30, 2018 to Mar 31, 2026. The TTM Arcturus Therapeutics (ARCT) revenue is $55M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Arcturus Therapeutics (ARCT) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -61.92% |
| 3 Years TTM | -42.04% |
| 5 Years TTM | +43.41% |
| All Time TTM | +17.98% |
Annual Revenue change of Arcturus Therapeutics (ARCT)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $2.06M | -97.49% |
| 2025 | $82M | -46.14% |
| 2024 | $152M | -8.69% |
| 2023 | $167M | -19.03% |
| 2022 | $206M | +1566.67% |
| 2021 | $12M | +29.56% |
| 2020 | $9.54M | -54.11% |
| 2019 | $21M | +32.00% |
| 2018 | $16M | N/A |
Comparison Arcturus Therapeutics (ARCT) five years revenue CAGR with competitors
Arcturus Therapeutics (ARCT) five years revenue CAGR is 43.41%.